Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Int J Cancer ; 118(3): 593-9, 2006 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-16094650

RESUMO

The effect of linoleic acid (LA) on growth and transformation of IEC6 intestinal cells was examined. IEC6 cells expressed mRNAs of 15-lipooxygenase (LOX15) and peroxisome proliferator-activated receptor (PPAR)gamma but not COX-2. Cell growth was suppressed by LA in a dose-dependent manner in IEC6 cells. Three-week treatment with LA provided IEC6 cells a quiescent state. LA-induced growth inhibition was abrogated by exposure to antisense S-oligodeoxynucleotides (S-ODNs) for LOX15 and/or PPARgamma. In an in vitro carcinogenesis model, IEC6 cells, which had confirmed CYP2E1 expression and activity, were continuously treated with AOM and/or LA for 40 weeks. DNA injury in AOM-treated cells was suppressed to the control level by concurrent LA treatment. Colony formation of AOM-treated cells in soft agar was suppressed by treatment with LA, which was reversed by exposure to antisense S-ODNs for LOX15 and/or PPARgamma. AOM-treated IEC6 cells formed s.c. tumors in 9 of 12 mice, whereas AOM+LA-treated cells formed no tumor. IEC6 cells showed no remarkable alteration of protein production by AOM treatment, whereas cells treated with AOM+LA showed decreased epidermal growth factor receptor (EGFR) and phospho-EGFR and increased BAX. These findings suggest that LA inhibited AOM-induced transformation of COX-2-negative IEC6 cells, which was possibly mediated with PPARgamma ligands generated by LOX15 from LA.


Assuntos
Azoximetano/toxicidade , Carcinógenos/toxicidade , Transformação Celular Neoplásica/efeitos dos fármacos , Mucosa Intestinal/efeitos dos fármacos , Ácido Linoleico/farmacologia , Neoplasias Experimentais/prevenção & controle , Animais , Araquidonato 15-Lipoxigenase/genética , Araquidonato 15-Lipoxigenase/metabolismo , Ciclo-Oxigenase 2/metabolismo , Citocromo P-450 CYP2E1/metabolismo , Dano ao DNA , Receptores ErbB/metabolismo , Técnicas In Vitro , Mucosa Intestinal/patologia , Ligantes , Inibidores de Lipoxigenase , Camundongos , Camundongos Endogâmicos BALB C , Neoplasias Experimentais/induzido quimicamente , Neoplasias Experimentais/patologia , Oligodesoxirribonucleotídeos Antissenso/farmacologia , PPAR gama/antagonistas & inibidores , PPAR gama/genética , PPAR gama/metabolismo , Fosforilação , Ratos , Proteína X Associada a bcl-2/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...